Clinical trial
Impact of Coenzyme Q10 and Meclofenoxate on Frequency and Severity of Hepatic Encephalopathy
NCT03961087 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Coenzyme Q10 and Meclofenoxate on Frequency and Severity of Hepatic Encephalopathy
- Lead sponsor
- Zagazig University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 23, 2019
- Completion date
- February 1, 2020
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coenzyme q10, hepatic encephalopathy, intellectual functioning disability